Previous studies have suggested that nitric oxide (NO) plays a role in regulation of renal vascular tone and sodium handling.
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A soluble enzyme, currently termed NO synthase, is involved in the formation ofNO and L-citrulhine from L-arginine (7, 8) . Synthesis of NO can be inhibited by L-arginine analogues such as L-N0-monomethyl-arginine (L-NMMA) and L-N0-nitroarginine-methylester (L-NAME) (9-1 1 ) . In vitro studies have demonstrated that NO activates soluble guanylate cyclase in target cells, such as vascular smooth muscle ( 12) and glomerular mesangial cells ( 13) , inducing a rise in levels of guanosine 3',5'-cyclic monophosphate (cGMP), which mediates subsequent physiological effects. Urinary cGMP levels have also been demonstrated to reflect activity of the NO system in vivo ( 14) .
Using this understanding of the basic physiology of the endogenous NO system, attention has recently focused on the role of this mediator in the regulation of vascular tone in vivo. By observing the effects in vivo ofendothelium-dependent agonists, such as acetylcholine, and NO synthase inhibitors, such as L-NMMA and L-NAME, it has become clear that NO plays a prominent role in regulation of renal hemodynamics and excretory function (15) (16) (17) (18) (19) (20) . When infused into the renal artery of the rat, L-NMMA induces a fall in GFR and renal vasoconstriction and a rise in filtration fraction ( 15 ) . Micropuncture studies in the rat during intravenous infusion of L-NMMA have demonstrated glomerular arteriolar vasoconstriction, with a predominant effect on the efferent arteriole, a decrease in the ultrafiltration coefficient, Kf, and an increase in glomerular capillary pressure, Pgc ( 16 ) .
Several investigators have reported that NO synthase inhibition in vivo induces natriuresis and diuresis ( 16, 17, 20) . Although some investigators have suggested that the increased excretion of sodium and water during NO inhibition is due to "pressure natriuresis" ( 18, 21 ) , others have hypothesized a direct tubular action of NO, observing that NO synthase inhibition results in decreased proximal reabsorption of sodium (20) . This issue has been complicated by the difficulty in separating direct renal effects of NO synthesis inhibition from systemic hemodynamic effects, such as increased arterial pressure and subsequent renal autoregulation, in the various experimental models. Chen and Sanders (22) recently suggested that activity of the endogenous NO system may be related to sensitivity or resistance to salt-induced hypertension in rats, further suggesting a role for NO in renal sodium handling, and, in particular, in adaptation to increased dietary salt loads.
Since NO is a very labile substance, direct measurement of NO has proven to be difficult, especially in vivo. Thus, much of the in vivo work to date has been limited to interpretation of the responses to NO synthase inhibitors. Although this is a useful approach, it is clear that it would be important to develop markers ofNO activity that could be quantitated in vivo. Tolins et al. ( 14) , previously demonstrated that, in the rat, hemodynamic responses to the endothelium-dependent vasoactive agonist, acetylcholine, correlated with urinary excretion of cGMP, and that the cGMP and hemodynamic responses to acetylcholine infusion could be inhibited by administration ofL-NMMA. These investigators suggested that urinary cGMP excretion could potentially be used as a biological marker of EDRF activity. More recently, Marletta et al. (23) demonstrated that NO decomposes rapidly in biological solutions into nitrite (NO2) and nitrate (NO3). These stable decomposition products can be measured as markers of NO production in vitro, as demonstrated in macrophages (23), vascular smooth muscle (24) , and glomerular mesangial cells (25) in culture. Recently, NO2 + NO3 have been used as markers of NO activity in vivo. Shultz and Raij (26) reported increases in levels ofNO2 + NO3 in the serum and urine ofrats treated with endotoxin. The increase in NO2 + NO3 levels was inhibited by coadministration ofthe NO synthase inhibitor, L-NAME. Furthermore, this inhibitory effect was overcome by administration ofexcess L-arginine, confirming that the NO2 + NO3 measured in the serum and urine after endotoxin reflected changes in NO production. Thus, urinary levels of cGMP, as well as serum and urine levels of NO2 + NO3, may be useful as in vivo "footprints" of activity of the NO pathway.
In the present studies we have used both the pharmacological inhibitors of NO synthase and markers of in vivo NO production to address the following questions: What is the effect of inhibition of NO synthase on renal hemodynamics and excretory function when the influence of systemic hemodynamic responses is eliminated? Does the endogenous NO system play a role in adaptation of the normal animal to increased dietary salt intake?
Methods
Studies were performed in male, Sprague-Dawley rats (275-375 g; Harlan Sprague Dawley, Inc., Indianapolis, IN). In study I we examined the effects of intrarenal NO synthase inhibition on renal hemodynamics and excretory function when renal perfusion pressure was kept constant with a suprarenal aortic snare. In study II we examined the effects of chronic exposure to a high dietary salt intake on endogenous NO activity.
Study L Role of increased renal perfusion pressure in the effects ofNO synthase inhibition on renal hemodynamics and excretoryfunction Clearance studies. Rats were anesthetized (Inactin, 100 mg/kg i.p.) and surgically prepared for determination of intra-arterial pressure, GFR, renal plasma flow (RPF), and urinary excretion of sodium, water and protein, by clearance techniques as previously described ( 14, 15) . The left femoral artery was cannulated with a PE-50 catheter for blood pressure monitoring (transducer model TNf; Gould Inc., Medical Products Div., Oxnard, CA) and blood sampling. Renal perfusion pressure (RPP) was assumed to be equivalent to the arterial pressure measured in the left femoral artery. A solution of normal saline containing [methoxy-3H]inulin (4 uCi/ml) and p-aminohippurate (PAH, 20 mg/ml; Merck Sharpe & Dohme, West Point, PA) was infused at a rate of 1.2 ml/h after a priming dose of0.5 ml. To maintain euvolemia, 5% bovine serum albumin in normal saline (Sigma Chemical Co., St. Louis, MO) was infused at 1.5 ml/h after a priming dose of 1% body weight. Timed urine collections were obtained from the left ureter for gravimetric determination of urine flow rate, with blood collected at the midpoint of each clearance period (250 1l).
For renal artery infusions, a PE-10 catheter with a curved attenuated tip was advanced in a retrograde fashion from the right femoral artery and placed in the orifice of the left renal artery under direct visualization. In this fashion, dissection and manipulation ofthe renal artery were unnecessary and thus potential denervation or vascular damage avoided. To maintain patency in the renal artery catheter, heparinized saline was infused at a rate of 0.5 ml/h when other agents were not being administered.
Analytical techniques. Radioactivity in urine and serum was quantitated by liquid-scintillation counting. PAH levels in urine and serum were determined by AutoAnalyser (Technicon Instruments Corp., Tarrytown, NY). Urine sodium was determined by flame photometer (Instrumentation Laboratory Inc., Lexington, MA). Urinary total protein excretion was assayed by the Coomassie dye method (Bio-Rad Laboratories, Richmond, CA). GFR and RPF were calculated with standard formulas. Renal blood flow (RBF) was calculated by dividing RPF by 1 -hematocrit and renal vascular resistance was calculated (RVR) by dividing RPP by renal blood flow.
Experimental protocols. Two groups of rats (n = 8 in each group) were studied after overnight fast. Group I rats (control) were allowed to equilibrate for 30 min after surgical preparation and then two baseline ( 15 min) clearances were performed. The intrarenal infusion was then changed to L-NMMA (generous gift of S. Moncada, Wellcome Research Laboratories, Beckenham, Kent, UK) dissolved in normal saline and delivered at 250 and 500ug -kg-' per min. There was a 1 5-min equilibration period at each dose level followed by two 1 5-min clearance periods. In group II (snare) rats, a length of suture was placed around the abdominal aorta, proximal to the renal arteries, during surgical preparation. The ends ofthe suture were suspended in an apparatus that allowed graded upward tension to be applied. Group II rats then underwent a protocol identical to that in group I with the exception that after the baseline clearances, the tension on the aortic snare was continuously adjusted to maintain RPP at baseline levels. An additional group of rats (n = 6) was prepared for clearance studies in a manner identical to that of group II (snare) except that no tension was applied to the aortic snare. Saline vehicle was infused into the renal artery (0.5 ml/h) for the duration of the experiment. Renal function was determined according to the exact protocol described above, thus providing a time-control group. Study I. Experimental protocols Effect of salt loading on serum NO2 + NO3 levels and urinary NO2 + NO3 excretion rates. Two groups of rats (n = 6 in each group) were studied. On day 0, while consuming standard rat chow and tap water ab libitum, all rats were placed in metabolic cages and urine was collected for 24 h in sterile tubes containing antibiotic/antimycotic solution (100 U/ml penicillin, 100 U/ml streptomycin, and 0.25 yg/ml amphotericin B). Blood was obtained by distal tail-vein sampling fordetermination of serum NO2 + NO3. Group III (control) was continued on standard rat chow and tap water ad libitum. Group IV (salt loaded) was provided the same chow, but was switched to 1% NaCl solution as drinking water. After 2 wk rats were placed in metabolic cages, urine collected for 24 h, and final blood samples obtained by cardiac puncture after brevital anesthesia.
Serum and urine samples were assayed for the stable NO end products, NO2 and NO3, as previously described (26) (27) (28) . Briefly, samples were incubated for I h at 370C with Escherichia coli nitrate reductase, prepared from bacteria grown under anaerobic conditions, effecting complete reduction of NO3 in the sample to NO2. NO2 in the sample was then quantitated using the Griess reagent, as previously described (25, 26, 29) . Known concentrations of NaNO2 and NaNO3 were used as standards in each assay and each sample was run in duplicate. The NO2 measured in this way reflects the sum of NO2 and NO3 in the original sample. Urinary excretion was calculated by multiplying the total concentration of NO2 + NO3 in each sample by 24-h urinary volume. Because rats exhibited significant increases in body weight over the course ofthe experiment, NO2 + NO3 values were normalized for body weight to allow comparison ofbasal and final values. Baseline and final urine samples were also assayed for cGMP concentration by radioimmunoassay as previously described (14, 25) and for sodium concentration by flame photometer.
Effect ofchronic salt loading on renal hemodynamic responses to NO synthase inhibition. Two additional groups of rats (n = 10 in each group) were studied. Group V (control) was provided standard rat chow and tap water, whereas group VI (salt loaded) received standard rat chow and 1% NaCl in the drinking water, for 2 wk. At the end ofthis time period rats in groups V and VI were surgically prepared for clearance studies to evaluate renal function before and after intrarenal infusion of the NO synthase inhibitor, L-NAME, infused at 50 and 125
Lg-kg-' per min using a protocol identical to that described above for group I rats. Pilot studies demonstrated that renal artery infusion ofthe higher dose of L-NAME (125 ug. kg-' per min) results in maximal renal hemodynamic responses (unpublished observations).
Statistical analysis
Data are presented as mean±SEM. Differences for parameters between baseline and subsequent time points within one group were compared by analysis of variance for repeated measures was observed for urine flow rate (Fig. 1 B) . In group I rats, L-NMMA infusion resulted in a dose-dependent increase in urine flow rate. In contrast, in group II rats, infusion of L-NMMA induced a marked antidiuretic effect. Fig. 1 C shows the effect of intrarenal L-NMMA infusion on urinary protein excretion rate. As can be seen in group I rats, when RPP is allowed to increase, the highest dose of L-NMMA induced a significant increase in protein excretion rate. The proteinuric effect of intrarenal L-NMMA was completely prevented when RPP was maintained at basal levels (group II). Thus, L-NMMA-induced proteinuria was dependent on a concomitant increase in RPP.
Study II. Effect ofsalt-loading on serum NO2 + NO3 levels and urinary NO2 + NO3 excretion rates II is shown in Fig. 1 . In control rats, in whom RPP was allowed to increase, a significant increase in sodium excretion compared with baseline was observed at both doses of L-NMMA ( Fig.. 1 A) a.
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Serum levels of NO2 + NO3 in group III and group IV rats at baseline and after the 2-wk experimental period are shown in Fig. 2 . Baseline values for serum NO2 + NO3 were not different between the two groups (Fig. 2 A) . After 2 wk the serum NO2 + NO3 was 41.1±+3.7 nmol * ml-' per 100 g body wt in control rats, a value not significantly different from baseline in this group. In contrast, the serum levels of NO2 + NO3 rose significantly in group IV (salt-loaded) rats to 51.9±3.6 nmol. ml-' per 100 g body wt. This value was significantly higher than baseline for this group (P < 0.05) and, in addition, was significantly higher than the 2-wk value in group II (control, P < 0.05). Fig. 2 B demonstrates a significant rise in urinary excretion of NO2 + NO3 in both the control (group III) and salt-loaded (group IV) rats between baseline and 2 wk (Fig. 2 B) . However, at the end ofthe 2-wk experimental period, urinary excretion of NO2 _+ NO3 was significantly higher in salt-loaded as compared with control rats (group IV vs. group III, 4,078±478 nmol * 24 h-' per 100 g body wt vs. 3,123±182 nmol -24 h-' per 100 gm body wt, P < 0.05). Thus, in these normal rats, salt loading was associated with a significant increase in the serum concentration and urinary excretion of NO2 + NO3. Furthermore, as shown in Fig. 3 , when baseline and final values ofrats in groups III and IV were considered, there was a highly significant correlation between urinary excretion of NO2 + NO3 and urinary sodium excretion (R2 = 0.728, P < 0.001).
Group III and group IV rats had similar urinary cGMP excretion rates at baseline (Fig. 4) , and cGMP excretion rate increased significantly compared with baseline after 2 wk in both groups of rats. However, as shown in Fig. 4 , salt-loaded rats (group IV) demonstrated a greater increase in urinary cGMP excretion rate, reaching a final level that was significantly increased as compared with control rats (group III). Similar to the urinary NO2 + NO3 excretion, urinary cGMP excretion was also significantly correlated with urinary sodium excretion (P < 0.001 ). Finally, we also found a significant and positive correlation between urinary excretion of NO2 + NO3 and cGMP (P < 0.01, data not shown), thus confirming an association between these three urinary parameters, and strongly suggesting that salt loading causes increased production of endogenous NO. the hemodynamic responses ofgroups V and VI to the highest dose of L-NAME, Fig. 5 shows these data expressed as percent change from baseline values. As can be seen in Fig. 5 A, the systemic pressor response was not different in control and saltloaded rats, however, the renal vasoconstrictor response to high-dose L-NAME tended to be greater in group VI (saltloaded) as compared with group V (control) rats (P = 0.06). The decrease in GFR and RPF, expressed as percentage change from baseline values, was significantly greater in salt-loaded as compared with control rats (Fig. 5 B) . Thus, in rats exposed to a high dietary salt intake for 2 wk, there was a greater renal hemodynamic response to maximal NO synthase inhibition than was observed in control rats.
Discussion
Over the last decade it has become increasingly apparent that, in addition to regulation of vascular permeability and control of hemostasis, the vascular endothelium is important in the regulation of vascular tone and regional hemodynamics (30) . Investigation in this area has made it clear that control ofvascular function by the endothelium is quite complex and involves the balanced synthesis and release of both vasodilator (prostacyclin, EDRF/NO) and vasoconstrictor (endothelin, endothelium-derived contracting factor) substances (31) . Modulation of regional hemodynamics by the endothelium has perhaps been best demonstrated by investigations into renal hemodynamics and excretory function. It has become clear that the vasodilatory action of acetylcholine, when studied in vitro, is due to stimulation and release of the EDRF, NO ( 1-3). Tolins and coworkers ( 14) recently demonstrated that the renal hemodynamic effects ofacetylcholine in vivo are also mediated by the EDRF, NO. In experimental animals acetylcholine infusion results in decreased systemic blood pressure, a large increase in glomerular capillary plasma flow, but no change in single-nephron GFR, resulting in a fall in filtration fraction (32, 33) . Acetylcholine infusion has also been reported to have a diuretic and natriuretic effect (33, 34) . Lahera et al. (35) reported that this acetylcholine-induced diuretic effect was dependent on intact NO synthase activity. Thus, in vivo experimental evidence suggests that stimulation of NO synthesis results not only in vasodilatation, but diuresis and natriuresis as well.
Further evidence supporting a role of NO in modulation of renal function has come from studies using inhibitors of NO synthase in vivo (15) (16) (17) (18) (19) (20) . These studies suggest that inhibition of endogenous NO synthase results in decreased GFR and renal vasoconstriction with a subsequent increase in filtration fraction. On a microcirculatory level, these changes are associated with a predominant vasoconstrictor effect on the postglomerular circulation, an increase in glomerular capillary pressure, and a fall in glomerular ultrafiltration coefficient. However, interpretation of these studies has been complicated due to the simultaneous systemic effects of these NO synthase inhibitors, resulting in increased RPP. It has remained unclear to what degree the effects of inhibition ofNO synthase on renal hemodynamics (increased RVR) and excretory function (diuresis and natriuresis) are direct or due to renal responses to increased RPP, such as autoregulation (36) and pressure natriuresis (37), respectively.
In this regard, Radermacher et al. (38) observed that both L-NMMA and nitro-L-arginine increased renal vascular resistance in the isolated perfused kidney of the rat, an experimental model free from systemic hemodynamic influences. Lahera et al. ( 18) investigated the renal functional response to intravenous infusions of L-NAME in the rat. They reported that during low-dose L-NAME infusion (1 igg kg-' per min i.v.), which did not significantly change systemic arterial pressure, there was a significant decrease in renal sodium and water excretion rate. In contrast, higher doses of L-NAME (50 ,g. kg-' per min) induced an increase in systemic blood pressure and were associated with a diuretic and natriuretic effect. Both these studies suggested that NO synthase inhibition had effects on renal hemodynamics and excretory function that were independent of systemic hemodynamic responses.
Study I was designed as an attempt to discern direct from indirect effects of NO synthase inhibition on both renal hemodynamics and excretory function. Our experimental model allowed evaluation of responses of the intact in situ kidney to maximal intrarenal NO synthase inhibition, while preventing any influence of alterations in RPP. We have demonstrated that the renal vasoconstriction and fall in GFR observed during NO synthase inhibition occur, and are perhaps accentuated, when renal perfusion pressure remains constant. This suggests that the renal hemodynamic effects of NO synthase inhibition are due to a direct action on the kidney and not secondary to adaptations such as renal autoregulation. In contrast, it is apparent that the diuresis and natriuresis observed during NO synthase inhibition are indeed secondary to and dependent on the concomitant increase in RPP, and thus represent a pressure natriuresis. These results are in agreement with the work of Johnson and Freeman (2 1), who previously suggested that systemic inhibition of NO synthase produces a pressure-dependent natriuresis. The results of study I are also consistent with previous reports of a natriuretic effect of agonists ofthe EDRF, NO, such as acetylcholine (33, 34) ; as well as the work of Alberola et al. (39) in which it was reported that, in the dog, the natriuresis and diuresis induced by extracellular volume expansion with saline was blunted during intrarenal L-NAME infusion. These previous studies suggest that stimulation of NO activity increases renal sodium excretion. Our data suggests that the direct renal effect of inhibition of NO activity is a decrease in sodium excretion. Taken together, these results suggest that activity ofthe endogenous NO system may play an important role in modulation of renal sodium handling.
In study I we also made the novel observation that acute NO synthase inhibition has a significant proteinuric effect and that this increase in protein excretion is completely prevented by fixing renal perfusion pressure at basal levels. This suggests that the proteinuric effect of NO synthase inhibition is secondary to acute hemodynamic alterations in association with an increase in RPP, most likely increased glomerular capillary pressure and increased filtration fraction (40) , hemodynamic changes previously observed during NO synthase inhibition by Zatz and DeNucci (16) . Because the increase in proteinuria was prevented in snared rats, we can speculate that the increase in glomerular capillary pressure observed after NO synthase inhibition ( 16) also depends on an increase in RPP and transmission of this pressure to the glomerular capillary bed. It is interesting that identical glomerular hemodynamic effects and proteinuria have been demonstrated during exogenous angiotensin II infusion in the rat (41 ) . Indeed, previous reports have suggested that part of the renal hemodynamic effect of NO synthase inhibition may be secondary to increased activity of angiotensin II within the glomerular circulation ( 15, 20) . It should be emphasized that the mechanism underlying L-NMMA-induced proteinuria was not directly addressed in the current study and so the importance ofglomerular microcirculatory effects must remain speculative.
The results of study I suggested that the endogenous NO system may play a role in renal sodium handling, with increased NO activity stimulating sodium excretion and decreased NO activity resulting in sodium retention. Furthermore, a recent report by Chen and Sanders (22) suggested that a defect in NO synthesis may underlie the phenomenon of salt-sensitive hypertension in rats. These investigators noted that, in Dahl rats, an increased dietary salt load resulted in increased activity of the NO system in salt-resistant, but not salt-sensitive rats. They hypothesized that the development of salt-sensitive hypertension may be secondary to an inability to enhance NO synthesis in response to increased dietary salt load. However, the conclusions of this study were based predominantly on the hemodynamic response to NO synthase inhibitors or the response to exogenous L-arginine, rather than direct measurements ofNO metabolites. Furthermore, it is possible that the defect in NO production in hypertensive Dahl rats is a result rather than a cause ofsalt-sensitive hypertension (42) . Study II was designed to further define the relationship between the adaptation to increased dietary salt intake and the endogenous NO system in normal rats.
In study II we observed that the serum concentration and urinary excretion of the NO decomposition products, NO2 + NO3, were increased in salt-loaded rats as compared with control rats, providing evidence that NO production increases in response to increased dietary salt intake in normal rats. Although the circulating and excreted NO2 + NO3 may not be exclusively derived from metabolism ofNO, our previous studies in rats given endotoxin (26) as well as a recent study using "5N-labeled substrate for NO synthase in humans (43) have established that changes in serum and urine levels of NO2 + NO3 do reflect in vivo production of NO. The source of the increased NO detected in response to increased dietary salt intake cannot be determined from the present studies. However, ex vivo incubations of tissues from rats exposed to endotoxin suggest that both vascular tissue and the kidney, particularly the glomerulus, are a major source of inducible NO production (26, 44) . Whether this holds true in the setting of salt-loading will need to be determined in future studies. The conclusion that NO production increases in response to increased dietary salt intake is supported by the finding of a significant correlation between urinary sodium excretion, a reflection ofintake, and urinary NO2 + NO3 excretion. Similarly, urinary sodium excretion also correlated with urinary cGMP excretion, another biological marker of NO activity in vivo (14, 26) . Moreover, there was a significant correlation between urinary NO2 + NO3 and cGMP excretion rates, providing further evidence that these two markers are related, most likely by reflecting endogenous NO activity. The urinary cGMP excretion rate was significantly increased in salt-loaded as compared with control rats. This latter finding must be interpreted cautiously, however, as an increase in atrial natriuretic peptide levels in response to salt loading could be contributory (44) .
The hemodynamic responses of rats in study II to NO synthase inhibition also support our conclusion that increased dietary salt intake increases endogenous NO activity. After 2 wk ofexposure to a high dietary salt intake, although baseline renal hemodynamic parameters were similar, intrarenal infusion of L-NAME was associated with a greater decrease in GFR and RPF and a tendency to an enhanced RVR response compared with control rats. This suggests that the basal renal hemodynamic state was characterized by enhanced endogenous NO activity in the salt-loaded group.
In summary, the current study demonstrates that inhibition of NO synthase in vivo results in direct renal hemodynamic and excretory effects, independent of changes in RPP. In particular, NO synthase inhibition is associated with a decrease in urinary sodium excretion when a concomitant increase in RPP is prevented. Furthermore, exposure of normal rats to a high salt diet for 2 wk induces increased NO production as determined by increases in serum concentrations of NO2 + NO3 and increased urinary excretion rate of NO2 + NO3 and cGMP. Chronically salt-loaded rats also demonstrated an enhanced renal hemodynamic response to NO synthase inhibition compared with rats with a normal salt intake. We conclude that the endogenous NO system participates in the physiological renal adaptation to increased dietary salt intake. Clarification of the role of NO in salt-induced hypertension and other pathological conditions associated with abnormal sodium homeostasis awaits future studies.
